The structural basis by which Hsp104 dissolves disordered aggregates and prions is unknown. A single subunit within the Hsp104 hexamer can solubilize disordered aggregates, whereas prion dissolution requires collaboration by multiple Hsp104 subunits. Here, we establish that the poorly understood Hsp104 N-terminal domain (NTD) enables this operational plasticity. Hsp104 lacking the NTD (Hsp104 DN ) dissolves disordered aggregates but cannot dissolve prions or be potentiated by activating mutations. We define how Hsp104 DN invariably stimulates Sup35 prionogenesis by fragmenting prions without solubilizing Sup35, whereas Hsp104 couples Sup35 prion fragmentation and dissolution. Volumetric reconstruction of Hsp104 hexamers in ATPgS, ADP-AlF x (hydrolysis transition state mimic), and ADP via small-angle X-ray scattering revealed a peristaltic pumping motion upon ATP hydrolysis, which drives directional substrate translocation through the central Hsp104 channel and is profoundly altered in Hsp104 DN . We establish that the Hsp104 NTD enables cooperative substrate translocation, which is critical for prion dissolution and potentiated disaggregase activity.
INTRODUCTION
Protein disaggregases hold potential to reverse protein aggregation and amyloidogenesis that underlie several fatal neurodegenerative disorders. Yet their structural and mechanistic basis of action is not understood. In yeast, a hexameric AAA+ protein, Hsp104, couples ATP hydrolysis to dissolution of disordered aggregates, preamyloid oligomers, and amyloid (Shorter, 2008) . Curiously, metazoa lack an Hsp104 homolog. Thus, it could be valuable to translate these Hsp104 activities to counter neurodegenerative disease . In yeast, Hsp104 confers two major selective advantages (Shorter, 2008) . First, Hsp104 confers tolerance to thermal and chemical stress by reactivating proteins trapped in disordered aggregates. Second, amyloid remodeling by Hsp104 enables yeast to deploy prions for adaptive purposes.
Hsp104 forms dynamic ring-shaped hexamers, which exchange subunits on the minute timescale Wendler et al., 2007) . Hsp104 harbors an N-terminal domain (NTD), two AAA+ nucleotide-binding domains (NBDs) that hydrolyze ATP, and a coiled-coil middle domain (MD) inserted in NBD1. Hsp104 drives protein disaggregation by coupling ATP hydrolysis to partial or complete substrate translocation across its central pore via interaction with conserved tyrosine-bearing pore loops (Shorter, 2008 ). Yet, the conformational changes of the hexamer and its central channel that drive substrate translocation are poorly resolved. Indeed, the hexameric structure of Hsp104 is unknown, and conflicting models have arisen from cryo-electron microscopy (EM) reconstructions of dysfunctional Hsp104 mutants in a limited number of nucleotide states (Carroni et al., 2014; Lee et al., 2010; Wendler et al., 2007 Wendler et al., , 2009 .
Hsp104 hexamers exhibit mechanistic plasticity and adapt distinct modes of intersubunit collaboration to disaggregate disordered aggregates versus amyloid. To disaggregate disordered aggregates, Hsp104 subunits within the hexamer collaborate noncooperatively via probabilistic substrate binding and ATP hydrolysis . By contrast, to resolve stable amyloid, several Hsp104 subunits within the hexamer cooperatively engage substrate and hydrolyze ATP . How this switch from noncooperative to cooperative mechanism occurs is not understood.
Hsp104 activity is potentiated by specific mutations in the MD . Potentiating mutations enable Hsp104 to dissolve fibrils formed by neurodegenerative disease proteins, including TDP-43, FUS, and a-synuclein (a-syn), and mitigate neurodegeneration under conditions where wild-type (WT) Hsp104 is inactive . These mutations reconfigure how Hsp104 subunits collaborate and increase plasticity such that robust disaggregase activity is maintained despite diverse subunit-inactivating events ). The precise domain requirements that underpin potentiation as well as operational plasticity are unknown.
Hsp104 harbors an NTD of poorly defined function, which is considered dispensable (Hung and Masison, 2006; Lum et al., 2008) . The NTD of ClpB, the E. coli Hsp104 homolog, contributes to substrate binding and disordered aggregate dissolution (Barnett et al., 2005) . However, several facets of Hsp104 activity are not conserved from ClpB . Unlike Hsp104, ClpB has limited ability to dissolve amyloid . Thus, whether NTD function is conserved from ClpB to Hsp104 is unclear. Indeed, replacing the Hsp104 NTD with the ClpB NTD disrupts prion propagation (Tipton et al., 2008 Park et al., 2014) . The direct effects of Hsp104 DN on Sup35 prionogenesis are unknown. Here, we define critical NTD functions in enabling Hsp104 plasticity and potentiation. Using pure components, we establish that Hsp104 DN dissolves disordered aggregates but not prions. In contrast to Hsp104, which breaks N-and C-terminal intermolecular prion contacts to release soluble Sup35 and eliminate cross-b structure, Hsp104 DN only breaks C-terminal intermolecular prion contacts and fragments Sup35 prions without solubilizing Sup35 or resolving cross-b structure. These differences reflect profound alterations in how Hsp104 Cells were plated and survival (%) calculated.
Values represent means ± SEM (n = 3; **p < 0.01; ***p < 0.001, two-tailed t test).
and Hsp104 DN hexamers coordinate substrate translocation. Indeed, the Hsp104 NTD enables cooperative substrate translocation by Hsp104, which is critical for potentiated activity and prion dissolution, but not for prion fragmentation.
RESULTS

Hsp104
DN Has Reduced Disaggregase Activity
Deletion of the Hsp104 NTD is reported to have minimal effect on disaggregase functionality (Hung and Masison, 2006; Lum et al., 2008) . This is not what we found. Hsp104 DN was hexameric and had elevated ATPase activity ( Figures 1A and 1B ). Hsp104 and Hsp104 DN solubilized disordered aggregates without Hsp70
and Hsp40 when provided with mixtures of ATP and ATPgS, a slowly hydrolyzable ATP analog ( Figure 1C ). However, at every ATP:ATPgS ratio tested, Hsp104 DN was slightly less active than Hsp104 ( Figure 1C ). At 2 ATP:1 ATPgS, Hsp104 was optimally activated, but Hsp104 DN was only $50% active ( Figure 1C ).
This distinct sensitivity to activation by ATPgS suggests that Hsp104 DN hexamers are tuned differently than Hsp104 hexamers. Specifically, under these conditions, Hsp104 DN hexamers require more ATPgS relative to ATP for maximal disaggregase activity ( Figure 1C ). Compared to Hsp104, Hsp104 DN displayed reduced disaggregase activity with different Hsp70s ( Figure 1D ). This deficit was most pronounced for Hsc70 and significant for Hsp72 (Figure 1D) . Hsp104 DN had reduced ability to disaggregate luciferase and confer thermotolerance in vivo ( Figures 1E and 1F ), despite similar expression levels to Hsp104. Thus, deletion of the Hsp104 NTD reduces disaggregase activity in vitro and in vivo. Hsp104 dissolves disordered aggregates via a noncooperative mechanism that does not require collaboration between Hsp104 subunits within the hexamer. Indeed, a single active Hsp104 subunit within the hexamer can drive disaggregation . By contrast, amyloid dissolution requires cooperative ATP hydrolysis and substrate binding by several Hsp104 subunits . In contrast to Hsp104, which disaggregated Sup35, Ure2, polyglutamine, and a-syn amyloid, Hsp104
DN was ineffective even at high concentrations Figure 2C ). At high concentrations, Hsp104 inhibits Sup35 prionogenesis ( Figure 2C ) (Shorter and Lindquist, 2006) . By contrast, even at very high concentrations, Hsp104 DN stimulated spontaneous Sup35 prionogenesis by reducing lag phase and accelerating assembly phase ( Figure 2D ). Thus, deletion of the Hsp104 NTD drastically alters the concentration-dependent effect of Hsp104 on Sup35 prionogenesis, such that inhibition of prion formation is diminished. Indeed, the absence of the NTD switches Hsp104 to an operating mode that stimulates Sup35 prionogenesis. Stimulation of spontaneous Sup35 prionogenesis by low concentrations of Hsp104 is due to two activities (Shorter and Lindquist, 2006) . First, Hsp104 reduces lag phase by accelerating formation of prionogenic Sup35 oligomers, which are recognized by an anti-oligomer antibody, A11. This activity requires ATP binding but not hydrolysis by Hsp104. Second, Hsp104 accelerates assembly phase by occasionally fragmenting Sup35 prions to generate additional fibril ends for conformational replication. This activity requires ATP hydrolysis by Hsp104.
We assessed the effect of Hsp104 DN on prionogenic Sup35 oligomer formation. Sup35 slowly formed A11-reactive oligomers that peaked at the end of lag phase ($4 hr) and rapidly disappeared during assembly phase ( Figure 2E ). High concentrations of Hsp104 prevented formation of A11-reactive species, whereas low concentrations of Hsp104 stimulated their appearance at 30 min, after which A11-reactive oligomers disappeared upon rapid prionogenesis ( Figures 2C and 2E ) (Shorter and Lindquist, 2006 Figure 2G ). At high concentrations, Hsp104 inhibited seeded Sup35 assembly (Figure 2G) . By contrast, even at high concentrations, Hsp104 DN accelerated seeded Sup35 prionogenesis ( Figure 2H ). Acceleration by Hsp104 DN required ATP hydrolysis, and was inhibited by AMP-PNP ( Figure 2H Figure 3A) , without reducing ThT fluorescence ( Figure 2A ). Fragmentation was confirmed by the ability of remodeled products to seed Sup35 prionogenesis ( Figure 3B ) Figure 3C ). High concentrations of Hsp104 eliminated Sup35 prions (Figures 2A and 3A-3C Figure 3C ). This effect was most pronounced at high Hsp104 DN concentrations ( Figure 3C ). Thus, the Hsp104 NTD is essential to dissolve Sup35 prions.
To determine how Hsp104 DN fragments Sup35 prions, we monitored intermolecular prion contacts. We employed the N-terminal prion domain (N, residues 1-121) and MD (M, residues 122-253) of Sup35, termed NM ( Figure 3D ). We assembled NM prions at 4 C to yield the prion ensemble NM4, which encodes predominantly strong [PSI + ] (DeSantis and Shorter, 2012) . Specifically, we assembled NM4 prions with 17 individual single cysteine NM variants labeled with pyrene at different positions. These pyrene-labeled NM variants retain WT assembly kinetics and infectivity, indicating that pyrene does not significantly alter prion structure (Krishnan and Lindquist, 2005) . Upon intermolecular contact formation, pyrene molecules at select positions, in the ''Head'' or ''Tail'' ( Figures 3D and 3E ), form excimers (excited-state dimers) that produce a strong red shift in fluorescence. Excimer fluorescence reports on intermolecular contact integrity, and NM prions are held together by intermolecular Head-to-Head and Tail-to-Tail contacts ( Figure 3D ) (Krishnan and Lindquist, 2005) . High concentrations of Hsp104 disrupted Head (residues 21-38) and Tail (residues 79-96) contacts of NM4 prions, whereas the low Hsp104 concentration also disrupted both contacts, but to a lesser extent ( Figure 3E ). By contrast, Hsp104 DN only disrupted Tail contacts even at high concentrations (Figure 3E) . Thus, the NTD is not required for Hsp104 to break the Tail contact, but is critical to break the Head contact and dissolve Sup35 prions. Figure 3F ). At early times (0-10 min), Hsp104 and 
Hsp104 Breaks the
Hsp104
DN broke the Tail contact (G86C), whereas the Head contact (G31C) remained intact ( Figure 3F ). At later times (20-60 min), Hsp104 severed Head contacts, but Hsp104 DN did not ( Figure 3F ). Thus, Hsp104 breaks the Tail and then the Head contact to remodel NM4 prions. This temporal separation suggested that Hsp104 and Hsp104 DN engage NM4 prions C-terminal to the Tail contact and then exert a directional pulling force that first breaks the Tail contact ( Figure 3D ). However, Hsp104 DN is unable to melt cross-b structure N-terminal to the Tail and releases after the Tail contact is broken but before the Head contact is broken. Figure 3G ). By contrast, with ATPgS, Hsp104 and Hsp104 DN were recovered only when BPMTS was attached at positions 96, 106, 112, 121, 137, and 151 ( Figure 3G ). Thus, Hsp104 and Hsp104
DN
initially engage NM4 prions C-terminal to the Tail contact, in a region spanning residues 96-151 ( Figure 3D ). Subsequently, Hsp104 DN breaks the Tail contact and fragments the prion, but is unable to release soluble NM, which requires unfolding the central core and severing the Head contact, a task accomplished by Hsp104. Second, we tracked the central core between the Head and Tail. Thus, we employed single cysteine NM variants bearing acrylodan labels at G43C, G51C, or Y73C, which lie in the central core ( Figure 3D ). Sequestration of labeled sites from solvent in the assembled prion increases acrylodan fluorescence at these positions (Krishnan and Lindquist, 2005) . Hsp104 DN failed to alter acrylodan fluorescence of NM4 prions ( Figure 3H ). Thus, Hsp104 DN does not remodel the central core. By contrast, Hsp104 reduced acrylodan fluorescence at these positions, indicating that the central core was remodeled and exposed to solvent ( Figure 3H ). Hsp104-driven unfolding of the central core was not concerted but occurred in a stepwise manner. Thus, the Y73 position displayed changes prior to G51 and G43, indicating that Hsp104 remodels C-terminal portions of the central core prior to N-terminal portions ( Figure 3H ). Thus, Hsp104 breaks the Tail contact and then unfolds the central core by pulling on its C-terminal end. Third, we assembled NM prions from single cysteine NM variants that were stapled together at the Head (N21C) or Tail (G96C) contact by an 11Å crosslinker 1,4-bis-maleimidobutane (BMB) (Krishnan and Lindquist, 2005) . NM4 prions stapled at the Head contact could be fragmented by Hsp104 and Hsp104 DN and were more potent seeds than untreated NM4 prions ( Figure 3I ). By contrast, NM prions stapled at the Tail contact could not be fragmented by Hsp104 or Hsp104 DN and seeded NM assembly just as well as untreated prions ( Figure 3I ). Thus, Hsp104 cannot break the Head contact until after the Tail contact has been broken. NM lacks the C-terminal GTPase domain of Sup35 ( Figure 3D ). Does Hsp104 need to unfold the C-terminal GTPase domain to dissolve Sup35 prions? Full-length Sup35 retains similar GTPase activity in the prion and soluble state (Krzewska et al., 2007) . Thus, to assess whether the Sup35 C-terminal domain was unfolded during Hsp104-catalzed prion dissolution, we included GroEL TRAP , which captures unfolded protein and prevents refolding. Hsp104 disassembled Sup35 prions, but GTPase activity was unchanged ( Figure 3J ), indicating that Hsp104 dissolves Sup35 prions without unfolding the C-terminal GTPase domain. Likewise, Hsp104 did not unfold GFP during dissolution of NM-GFP prions (Figures S1C and S1D). Thus, Hsp104 selectively resolves N-terminal prion structure without unfolding the appended C-terminal domain.
Hsp104
DN Has Impaired Translocation and Unfoldase
Activity
The inability to resolve cross-b structure or break Head contacts of NM4 prions suggested that Hsp104 DN might be defective in substrate translocation and unfolding. Indeed, FITC-casein degradation and RepA 1-70 -GFP unfolding assays confirmed that Hsp104 DN has impaired translocation and unfoldase activity (Figures S1E and S1F).
(E) NM4 prions carrying pyrene labels at the indicated single site were treated with Hsp104 or Hsp104 DN plus Sse1, Ssa1, and Sis1 for 1 hr. The ratio of excimer to nonexcimer fluorescence (I 465nm /I 375nm ) was then determined. Values represent means (n = 3).
(F) NM4 prions carrying pyrene labels in the Head (G31C) or Tail (G86C) were incubated with Hsp104, Hsp104 DN , or Hsp104 DWB (1 mM) plus Sse1, Ssa1, and Sis1 for 0-1 hr. At various times, the ratio of excimer to nonexcimer fluorescence (I 465nm /I 375nm ) was determined and compared to the zero time point to determine contact integrity (%). Values represent means ± SEM (n = 3).
(G) Mapping contact sites between NM4 prions and Hsp104+ATPgS, Hsp104+ADP, Hsp104 at a structural level, we examined changes in shape of Hsp104 and Hsp104 DN hexamers through the ATPase cycle in solution using small-and wide-angle X-ray scattering (SAXS/WAXS). Xray scattering at very low angles provides information about particle size and shape. Hsp104 and Hsp104 DN were hexameric and monodisperse in solution and ideally suited for SAXS ( Figure 1A ; and see calculated mass of particle [MM by Qr] in Table S2 ).
We measured scattering at multiple concentrations and different beamlines and obtained very similar results (Table S2 ). Guinier analysis confirmed the absence of aggregation or other concentration-dependent effects ( Figure S2A ) . Thus, we determined structural parameters of Hsp104 and Hsp104
DN
, including maximum dimension (D max ) and radius of gyration (R g ) in six nucleotide states-AMP-PNP, ATPgS, ATP, ADP-AlF x (ATP hydrolysis transition state mimic), ADP, and no nucleotide-to simulate the steps of the ATP hydrolysis cycle. Data were measured to a q max of $0.7-0.8 Å À1 to yield a nominal resolution limit (2p/q max ) of 7.6-8.4 Å . Raw scattering profiles (I[q] versus q, where q = 4p[sinq]/l) and GNOM (Svergun, 1992) fits to experimental data revealed large differences between Hsp104 and Hsp104 DN ( Figure 4A ). Distinctive features in the low q region present in Hsp104, but not Hsp104 DN (corresponding to the NTD), are highlighted ( Figure 4A , inset). In the absence of nucleotide, Hsp104 and Hsp104 DN hexamers have their largest R g and D max ( Figure 4B ; Tables S2 and  S3 ). Addition of nucleotide decreased R g and D max ( Figure 4B ; Tables S2 and S3 ). For Hsp104 and Hsp104 DN , AMP-PNP and ATPgS elicited larger spatial properties ( Figure 4B ; Tables S2  and S3 ). ADP-AlF x , which mimics the ATP hydrolysis transition state, where ADP and Pi are bound, yielded the smallest R g and D max values for Hsp104 and Hsp104 DN ( Figure 4B ; Tables   S2 and S3 ). The spatial properties of Hsp104 and Hsp104 DN then expand slightly upon Pi release in the ADP state ( Figure 4B ; Table S3 ). Thus, Hsp104 and Hsp104 DN hexamers contract upon ATP hydrolysis and expand upon ATP binding ( Figure 4B ; Tables  S2 and S3) , indicating a pumping mechanism to drive substrate translocation. Structural changes of Hsp104 and Hsp104 DN hexamers were evident in the real-space pairwise distance distribution function, or P(r), which represents the distances between pairs of atoms within a given volume. As with R g , the apparent redistribution of interatomic vectors in the P(r) curves demonstrates that nucleotide addition and identity induce specific changes in shape for Hsp104 and Hsp104 DN hexamers ( Figures 4C and 4D ). How the Hsp104 hexamer responds to a given nucleotide, both in terms of the magnitude and the specific effect, differs in the absence of the NTD ( Figures 4C and 4D ).
To visualize these changes, we employed the ab initio modeling program GASBOR ) to derive volumetric reconstructions of the averaged solution shape of Hsp104 and Hsp104
DN hexamers with each nucleotide. GASBOR employs simulated annealing to match experimental scattering data with an ensemble of beads corresponding to the composition of the particle. For each nucleotide, GASBOR calculations were performed ten times using scattering data to q max of 0.7-0.8 Å À1 (nominal resolution limit of 7.6-8.4 Å ). GASBOR calculations using q max truncated to 0.5 Å À1 or calculations with the program DAMMIN/F yielded similar results. We imposed 6-fold symmetry based upon cryo-EM analyses of Hsp104 (Wendler et al., 2007) . Superposition of each GASBOR solution for Hsp104 and Hsp104 DN (Figures S2B and S2C) revealed consensus that was confirmed by the normalized spatial discrepancy (NSD) between independent calculations. NSD indicates the degree of discrepancy between the same relative position between any two structures . NSD values indicated little deviation between independent calculations, and reconstructions from different synchrotron trips yielded similar results (Figures 4E-4G ; Table S2 ). The outputs of each GASBOR calculation were averaged to provide filtered and unfiltered densities using DAMAVER ( Figures 4E-4G ) . Hsp104 shape reconstructions were oriented using Hsp104 DN hexamers, which when overlaid indicated where density for the missing NTD would fit ( Figure 4F ). The general dimensions of Hsp104 and Hsp104 DN particles determined by SAXS agree with Hsp104 N728A and Hsp104 DN cryo-EM reconstructions (Wendler et al., 2007) , and the central channel through which substrate is translocated is resolved ( Figures 4E-4G Figures 4E and 4G ). Two distinctive features change in each nucleotide state: (1) the placement of a projection of density on the hexamer exterior, along the plane of the largest dimension; and (2) the diameter and contours of the central channel ( Figures 4E-4G , 5A, and 5B). The exterior projection is evident in the P(r) as a small population of large vectors that start around 175 Å ( Figures 4C and 4D ). Hsp104 and Hsp104 DN have dynamic projections that shift from a more (B) R g of Hsp104 and Hsp104 DN with the indicated nucleotide calculated by GNOM. These values closely match the Guinier approximations for R g (Table S2 ).
Values represent means ± SEM (n = 3-7).
(C and D) Real-space shape information for Hsp104 and Hsp104 DN . Normalized P(r) curves (density distribution plots) generated by GNOM for Hsp104 (C) and Hsp104 DN (D) in the presence of AMP-PNP, ATPgS, ATP, ADP-AlF x , ADP, and no nucleotide. P(r) plots are normalized to the area under the curve and overlaid to show differences between nucleotide states. Insets display the P(r) peak, which reveals differences between nucleotide states. Compared to Hsp104, Hsp104 See also Tables S2 and S3 , Figure S2 , Movie S1, and Movie S2.
N-terminal position (in no nucleotide, AMP-PNP, ATPgS, and ATP) to a more C-terminal position (in ADP-AlF x and ADP) upon ATP hydrolysis ( Figures 4E-4G , 5A, and 5B; Movie S1 and Movie S2). Rudimentary rigid body domain fitting reveals that the volumetric envelopes readily accommodate six Hsp104 monomers ( Figure S2D ). The external projection is likely the MD in accord with cryo-EM models of HAP plus ATPgS and ClpP ( Figure S2D ) (Carroni et al., 2014) . Thus, our SAXS reconstructions resolve controversy surrounding MD location generated by cryo-EM studies (Lee et al., 2010; Wendler et al., 2007 Wendler et al., , 2009 . The change in position of the external projection ( Figures  4E-4G ) is consistent with the MD located on the surface of the hexamer, which can move from an N-terminal, horizontal position to a C-terminally tilted position (Carroni et al., 2014; . To disaggregate substrates, Hsp104 translocates proteins through its central channel. Thus, we focused on the central channel ( Figures 5A and 5B) . The changes in shape of the Hsp104 channel are reminiscent of a peristaltic wave: there is dilation at the site of substrate entrance followed by a wave of constriction that travels in the direction that substrate is being pumped. Substrate enters through the N-terminal entrance and can be expelled from the C-terminal exit (Shorter, 2008) . Accordingly, in the ATPgS state where Hsp104 initially engages substrate, the N-terminal channel entrance of Hsp104 is open and dilated with a diameter of $45-50 Å ( Figure 5A ). In the ATPgS state, there is a region of constriction (channel diameter $18 Å ) after the N-terminal opening ( Figure 5A, arrow) , and C-terminal to this constriction the channel is $25-30 Å in diameter. The channel constricts to a diameter of $25-30 Å across its entire length with the transition state mimic ADP-AlF x (Figure 5A ), the state with the smallest R g ( Figure 4B ). Thus, upon ATP hydrolysis the Hsp104 channel constricts ( Figure 5A ). In the ADP state, a C-terminal point of constriction becomes apparent ( Figure 5A , arrow), which likely helps expel substrate from the C-terminal exit. Thus, cycles of ATP binding and hydrolysis drive a peristaltic pumping motion of the Hsp104 hexamer, which likely drives directional substrate translocation (Movie S1). The peristaltic pumping motion likely underpins how Hsp104 transduces energy from ATP hydrolysis to conformational change and substrate remodeling using physical force.
NTD deletion grossly perturbs this peristaltic pump motion ( Figure 5B ; Movie S2). In ATPgS, the Hsp104 DN channel is narrow in diameter ($16-30 Å ) compared to Hsp104, and there is no dilation at the N-terminal entrance ( Figures 5A and 5B) . Thus, it is more difficult for substrate to access the Hsp104 DN channel in the binding-competent ATPgS state. In ADP-AlF x , the Hsp104 DN channel is dilated at N-and C-terminal ends, and only a central portion of the channel is $25-30 Å in diameter, unlike Hsp104, where the channel aperture is $25-30 Å across its whole length ( Figures 5A and 5B) . Thus, the ''power stroke'' motion elicited by ATP hydrolysis in Hsp104 is profoundly altered in Hsp104 DN . In ADP, the Hsp104 DN and Hsp104 channels change in diameter in a similar manner along their length, although the N-terminal channel entrance is more dilated in Hsp104 DN ( Figures 5A and 5B Figure 6C ). We could model this behavior if we imposed rules whereby an Hsp104 DNDPL subunit stimulates the activity of an adjacent Hsp104 DN subunit by $2-fold but exerts an inhibitory effect if it is adjacent to a mutant subunit ( Figure 6C) Figure 6D ). Thus, all six Hsp104 subunits must possess the NTD for globally cooperative prion dissolution.
Hsp104
DN Is Not Potentiated by Mutations in the MD
Hsp104 disaggregase activity is potentiated by specific mutations in the MD, which enable Hsp104 to dissolve TDP-43, FUS, and a-syn fibrils and mitigate neurodegeneration under conditions where Hsp104 is inactive Figure 1D ), which might also contribute to reduced amyloid dissolution. However, amyloid dissolution by Hsp104 does not typically require Hsp70 and Hsp40 (DeSantis et al., 2012); thus we suggest that altered subunit cooperativity is the major defect limiting amyloid dissolution by Hsp104 DN . Cryo-EM reconstructions of Hsp104 have fueled controversy, and a clear picture of how Hsp104 drives protein disaggregation has not emerged from these studies. Controversy has been compounded by the use of only dysfunctional Hsp104 mutants in a limited number of nucleotide states: only ATPgS, ATP, and ADP have been explored (Carroni et al., 2014; Lee et al., 2010; Wendler et al., 2007 Wendler et al., , 2009 ). It is difficult to relate these findings to WT Hsp104. To provide an independent view, we employed SAXS, a powerful method to study structural changes of AAA+ proteins in solution (Chen et al., 2010) . SAXS is performed in solution, under conditions where Hsp104 is active, eliminating issues caused by freezing or fixation in cryo-EM. We reconstructed Hsp104 and Hsp104 DN in AMP-PNP, ATPgS, ATP, ADP-AlF x (hydrolysis transition state), ADP, and apo states to a nominal resolution of 7.6-8.4 Å . Thus, we provide the highestresolution and most comprehensive set of volume envelopes for Hsp104 (which has not been studied by cryo-EM) and Hsp104 DN hexamers to date. By studying Hsp104 in various nucleotides, we uncover hexameric states that are likely populated during its natural ATPase cycle. We revealed a peristaltic pumping motion of the central channel that drives directional substrate translocation, which is profoundly altered in Hsp104 DN . This finding helps explain several functional deficits of Hsp104 DN .
However, pore shape is unlikely to be the only determinant of substrate translocation, and it is critical to define the location of the substrate-binding pore loops in each nucleotide state. Future studies will fit atomic models of Hsp104 monomers into these SAXS envelopes and will be constrained by X-ray footprinting data . We have elucidated the mechanism of Sup35 prion severing and dissolution by Hsp104. Hsp104 engages Sup35 prions by binding to a region spanning amino acids 96-151 ( Figure 7G , purple regions). Hsp104 then exerts a directional pulling force that selectively unfolds cross-b structure N-terminal to this binding site, but does not unfold domains C-terminal to this binding site ( Figure 7G ). This partial translocation mechanism enables Hsp104 to dissolve Sup35 prions without unfolding the C-terminal GTPase domain ( Figure 7G ). Thus, Hsp104 rapidly releases functional, folded protein from the prion to rapidly cure the loss-of-function [PSI + ] phenotype (Paushkin et al., 1996) . After engaging the prion, Hsp104 resolves cross-b structure N-terminal to its binding site in three steps: (1) the Tail-to-Tail contact is broken ( Figure 7G , dark green regions), (2) the central cross-b core is unfolded ( Figure 7G , blue regions), and (3) the Head-to-Head contact is broken to release soluble Sup35 (Figure 7G, red regions) . This sequence was confirmed by covalently stapling the Tail-to-Tail or Head-to-Head contact with BMB. Thus, Hsp104 severed prions with a covalent Head-to-Head contact by breaking the Tail-to-Tail contact, but could not fragment prions with a covalent Tail-to-Tail contact.
Hsp104 DN is specifically defective in the second and third steps of this process. Hsp104 DN engages the same binding site on Sup35 prions and breaks the Tail-to-Tail contact. However, Hsp104 DN is unable to unfold the central core or break the Head-to-Head contact. Thus, Hsp104 DN is capable of fragmenting but not dissolving Sup35 prions ( Figure 7G ). (Park et al., 2014) . It was proposed that Hsp104 DN promotes Sup35 prion dissolution via a ''trimming'' activity that solubilizes Sup35 only from the ends of prion fibrils (Park et al., 2014) . Our findings provide a rationale for this proposed activity. by Hsp104 overexpression are inconsistent with inhibition of prion fragmentation (Park et al., 2014) . This mechanism also fails to explain why Hsp104 DN cures [PSI + ] in some genetic backgrounds (Park et al., 2014) . We have established that the NTD is essential for potentiation of Hsp104 activity by specific MD mutations. Unlike their fulllength counterparts, neither Hsp104 DN-A503V nor Hsp104
DN-A503S
rescued TDP-43, FUS, or a-syn toxicity in yeast. Potentiating mutations at the A503 position of the MD likely promote an allosteric activation step that enhances Hsp104 ATPase, unfoldase, and disaggregase activity . These effects are ablated by NTD deletion. We conclude that optimal Hsp104 functionality depends on the NTD, which enables hexamer plasticity and potentiation.
EXPERIMENTAL PROCEDURES Proteins
Proteins were purified using standard protocols. For more details, see Supplemental Experimental Procedures.
Size-Exclusion Chromatography
Absolute molecular weights of apo hexamers of Hsp104 and Hsp104 DN (15 mM monomer) were determined using multiangle light scattering coupled with refractive interferometric detection and a TSK4000 size-exclusion column.
NTPase Activity Hsp104 ATPase and Sup35 GTPase activity was assessed as described Krzewska et al., 2007) .
Protein Disaggregation
Luciferase disaggregation and reactivation in vitro and in vivo were as described . Amyloid and prion disaggregation was as described . For more details, see Supplemental Experimental Procedures.
Thermotolerance
Yeast thermotolerance was assessed as described .
Sup35 Prionogenesis and Transformation
Sup35 prionogenesis in vitro and transformation were performed as described (DeSantis and Shorter, 2012; Shorter and Lindquist, 2006) . For more details, see Supplemental Experimental Procedures.
Site-Resolved Pyrene and Acrylodan Fluorescence
Pyrene and acrylodan fluorescence were monitored as described (Krishnan and Lindquist, 2005) .
Site-Resolved BPMTS Crosslinking
Single cysteine NM variants (10 mM) bearing BPMTS at the indicated position were assembled into prions with agitation at 1,400 rpm (Eppendorf thermomixer) in the dark. Crosslinking was elicited by UV irradiation at 365 nm for 20 min. Samples were processed for reducing SDS-PAGE and immunoblot. For more details, see Supplemental Experimental Procedures.
SAXS/WAXS
X-ray scattering data were collected at beamline 4-2 at Stanford Synchrotron Radiation Laboratory (SSRL, Menlo Park, CA) and beamline X9 at the National Synchrotron Light Source (NSLS, Upton, NY). Data were collected and analyzed as described . Shape reconstructions of the hexamer were generated using GASBOR ). Six-fold symmetry was imposed. Reconstructions were averaged and filtered using DAMAVER and converted to volume envelopes using SITUS Wriggers et al., 1999) . For more details, see Supplemental Experimental Procedures.
Mutant Doping Studies
Mathematical modeling and mutant doping studies were as described .
Yeast Proteinopathy Models
Yeast strains integrated with galactose-inducible TDP-43, FUS, or a-syn were transformed with the indicated galactose-inducible Hsp104 variant or vector. Toxicity, aggregation, and expression were assessed as described .
ACCESSION NUMBERS
The SAXS data have been deposited in BIOISIS, an open-access database dedicated to the study of biological macromolecules by SAXS (http://www. bioisis.net/). The accession codes are available upon request from the authors. substrates into a chambered protease, ClpP RepA are appended to GFP and serve as a recognition signal for Hsp104 (Doyle et al., 2007) . To track RepA 1-70 -GFP unfolding by Hsp104 or Hsp104 ∆N in the absence of subsequent refolding, we added GroEL TRAP (Doyle et al., 2007 
SUPPLEMENTAL INFORMATION
RepA 1-70 -GFP unfolding assay
RepA 1-70 -GFP unfolding assays were performed as described (Doyle et al., 2007; Jackrel et al., 2014) . Briefly, RepA 1-70 -GFP (0.7µM) was treated with Hsp104 or Hsp104 ∆N (1µM) plus either 2.5mM ATP and 2.5mM ATPγS (1:1) or 3.33mM ATP and 1.67mM
ATPγS (2:1), GroEL TRAP (1.5µM), 0.02mg/ml BSA, and 0.005% (v/v) Triton-X100 and an ATP regenerating system (1mM creatine phosphate, 0.25µM creatine kinase) in LRB.
The decrease in fluorescence (excitation: 395 nm; emission: 510 nm) over a period of 60min was monitored using a Tecan Infinite M1000.
Small-and wide-angle x-ray scattering (SAXS/WAXS)
X-ray scattering data were collected at beamline 4-2 at the Stanford Synchrotron Radiation Laboratory (SSRL, Menlo Park, CA), and beamline X9 at the National Synchrotron Light Source (NSLS, Upton, NY) (details specific to each beamline are provided below). Data were collected at multiple concentrations between 1.5mg/ml and 6mg/ml. Samples were oscillated in quartz capillaries during data collection to minimize radiation damage. The two-dimensional scattering images were collected on CCD detectors, and circularly averaged using software developed at the individual beamlines to yield one-dimensional scattering profiles as a function of momentum transfer q (in Å -1 , where q=4πsin(θ)/λ, where 2π is the scattering angle and λ is the wavelength). The raw scattering data were scaled and buffer subtracted using the program PRIMUS (Konarev et al., 2003) . Each individual scattering profile was visually inspected for radiation damage and aggregation prior to averaging, including Guinier and Kratky plot analysis. For data collected at NSLS, where both SAXS and WAXS data are collected on separate detectors simultaneously, averaged scattering profiles from the SAXS and WAXS detectors were scaled and merged in PRIMUS to yield a composite profile encompassing all of the recorded scattering angles. The parameters derived from classical Guinier analysis (Rice, 1956 ) (R g , and I(0)) corresponded well with those derived from distance distribution functions. P(r) were calculated by the program GNOM (Svergun, 1992) using the indirect Fourier transform. The maximum dimension of the particle (D max ) was determined by examining the quality of fit to the experimental data for a D max range of 180Å to 280Å, varied in 5Å increments. Fits were optimized by three criteria: (1) maximizing the Total Estimate metric; (2) minimization of the discrepancy between calculated and experimental profiles; and (3) optimizing the visual properties of the shape distribution function. The Porod volume and Porod exponent values were calculated by the Javabased program ScÅtter (http://www.bioisis.net/tutorial/9). The mass of the particle was confirmed by Qr calculations, as previously described (Rambo and Tainer, 2013) .
SAXS data were collected at beamline 4-2 at the Stanford Synchrotron Radiation Laboratory (SSRL, Menlo Park, CA) at room temperature with a sample to detector distance of 1600mm. Using software developed at the beamline, two-dimensional scattering profiles collected using a Rayonix MX225-HE detector were converted into one-dimensional intensity profiles. The x-ray wavelength was 1.2Å, providing an accessible q where 0.0140<q<0.4435Å -1 . The protein samples and matching buffer solutions, 30µl for each measurement, were exposed for ten 10s exposures in a 1.2mm
path capillary with thin mica windows sealed across the evacuated flight path with oscillation. Each exposure was checked for radiation damage by the automated software prior to averaging. After each measurement the capillary was washed thoroughly and purged with compressed nitrogen.
SAXS and WAXS data were collected simultaneously at beamline X9 at the National Synchrotron Light Source (NSLS, Upton, NY) at 10°C, or 25°C for the ADP-AlF x state, by two overlapping detectors, a Mar 165 CCD SAXS detector 3.4m from the sample, and a custom built Photonic Science CCD WAXS detector. The two-dimensional images were converted into one-dimensional scattering profiles using software developed at the beamline. The x-ray wavelength was 0.855Å. Between the two detectors configurations, an accessible q of 0.0055<q<1.0Å -1 was achieved. Data to q max of 0.795Å -1 was used for data analysis and reconstructions. The sample cell contained a glass capillary sealed across the evacuated chamber. The protein samples and matching buffer solutions were flowed through the capillary and oscillated during exposure to reduce radiation damage.
For data collection 30µl of the protein sample or matching buffer solution was exposed for 180s, subdivided into three 60s exposures of 10µl. Our SAXS data will be deposited at BioIsis.net upon publication.
Shape reconstructions from SAXS/WAXS data
Shape reconstructions of the hexamer were generated using the program GASBOR . Information required for GASBOR modeling is the x-ray scattering profile, the number of residues to be modeled (GASBOR assigns a dummy reside to represent each residue), and the D max . Six-fold symmetry was imposed. Since each inverse scattering has no one unique solution, GASBOR calculations were performed ten times using all of the recorded scattering data to q max of 0.7-0.8 Å -1 ;
GASBOR calculations using q max truncated to 0.5Å -1 or calculations with the program DAMMIN/F yielded similar results. Regions that are flexible are assigned different positions in individual simulations. The ten independent dummy residue reconstructions were aligned and scored based on the normalized spatial discrepancy (NSD) (Kozin and Svergun, 2001 ). The individual reconstructions were only included if their NSD < mean NSD + 2 * variation. The included reconstructions were averaged and filtered to yield a final most-probable model using the DAMAVER suite of programs (Svergun and Koch, 2003; Volkov and Svergun, 2003) . The individual bead models were visualized in PyMOL (http://www.pymol.org). The filtered and unfiltered average models were converted to volume envelopes using SITUS (Wriggers et al., 1999) and visualized using Chimera (Pettersen et al., 2004) .
Channel reconstructions from SAXS/WAXS data
The SITUS maps were converted to MRC-format maps using map2map, part of the SITUS suite of programs (Wriggers et al., 1999) . The three-dimensional electron density file in the MRC format was imported into Matlab (Mathworks) using a custom script, which parses the file into a three-dimensional matrix of electron density. The read function also extracts the voxel dimensions to scale the measurement. The built in Matlab function "edge" was used to find the edges of two-dimensional slices of the electron density using the Sobel method. The Sobel method finds the edges by approximating the first derivative over the image; maxima of the first derivative are edges.
The density matrix was oriented such that the Z-axis moved through the central channel of the Hsp104 hexamer. Two-dimensional X-Y slices are torroidal slices of the density where the central cavity is the channel. A custom script was used to find edges for each two-dimensional slice of the density matrix. The X, Y and Z coordinates of each edge point were stored in an array and were scaled by the voxel dimensions. This array can be interpreted as a list of three-dimensional vectors that all point from one corner of the density matrix (0,0,0) to voxels, which lie upon the edge of the channel. The built in
Matlab function "convhulln" was used to convert the vector array into a convex hull and measured the volume of the hull. The convex hull is the shell of the channel and the volume is the volume of the Hsp104 hexamer channel.
A distance was measured for each slice of the channel to determine its width. First, edges were found for each slice using the Matlab function "edge". Two mid-lines of the channel were extracted, one horizontal and one vertical, and the scaled distance from edge to edge was measured. The two-dimensional slice was then rotated over 45 degrees in 5 degree increments for a total of 18 channel width measurements of each two-dimensional slice.
The average of the 18 channel width measurements is reported. The algorithm was then iterated over every Z-slice of the density to measure the channel widths through the channel. We have made the custom scripts generated for measuring channel width and volume from SAXS MRC files available at:
http://www.mathworks.com/matlabcentral/fileexchange/47095-saxs-channel-width-and-
volume-measurement
Mutant doping studies
Here, mutant Hsp104 subunits with specific defects (e.g. substrate translocation) are mixed with WT subunits to generate heterohexamer ensembles. Incorporation of mutant subunits into hexamers occurs according to a binomial distribution dictated by the WT:mutant ratio ( Figure 6A ) Werbeck et al., 2008) . Theoretical activities for each ratio of WT:mutant can be determined based on the fraction of each type of heterohexamer present and how many active subunits per hexamer are required for activity ( Figure 6A , B) Werbeck et al., 2008) . If cooperativity
